Changchun Wancheng Bio-Electron Recalls Male Fertility Sperm Tests Due to Lack of FDA Clearance
Changchun Wancheng Bio-Electron Co., Ltd. is recalling 1,000 home sperm test kits distributed in the U.S. because the devices were marketed without required regulatory approval.
What Happened
Changchun Wancheng Bio-Electron Co., Ltd. has initiated a voluntary recall of its Male Fertility Sperm Test for Home Use (Cassette). The recall was prompted because the test strips and diagnostic components were distributed to U.S. customers before they could be legally marketed through the required 510(k) clearance process. According to the FDA, these unapproved devices may produce false or inaccurate diagnostic results, which could lead consumers to pursue inappropriate medical interventions.
Which Products Are Affected
The recall involves approximately 1,000 units of the following product:
- Product Name: Male Fertility Sperm Test for Home Use (Cassette)
- Lot Number: GT-SPA 20251601
- Expiration Date: 05-2027
- Recall Number: Z-1262-2026
The affected products were distributed nationwide within the United States, with confirmed distribution in Texas, Georgia, and California.
What You Should Do
Consumers who have purchased the affected test kits should stop using them immediately. The recalling firm, Changchun Wancheng Bio-Electron Co., Ltd., initiated the notification process via letter. Consumers seeking information regarding returns or refunds should contact the firm at their headquarters at 2336, Tianwei Road, Beihu Science and Technology Development Zone, Changchun, China.
Why This Matters
The use of diagnostic tests that have not been cleared by the FDA poses a risk of inaccurate health data. Inaccurate results from a fertility test could lead to incorrect self-diagnosis and unnecessary or harmful medical decisions.
Source
Information provided by the FDA.
Source: FDA Official Notice
Related Articles
Exploro Male Fertility and Sperm Concentration Tests Recalled Due to Lack of FDA Clearance
FDA · February 17, 2026
Biomerieux Inc Recalls VITEK 2 Gram-negative Susceptibility Cards Due to Potential for False Test Results
FDA · February 17, 2026
Olympus Recalls Single Use 3-Lumen Sphincterotome V Due to Potential Device Deformation
FDA · February 17, 2026